confirm
infect
new
coronaviru
sarscov
caus
sever
acut
respiratori
syndrom
sar
diagnost
assay
detect
sarscov
specif
antibodi
necessari
evalu
diagnost
perform
laboratori
extern
qualiti
assur
eqa
studi
perform
particip
laboratori
correctli
detect
antisar
antibodi
serum
sampl
without
fals
posit
result
immunofluoresc
assay
contrast
laboratori
detect
antisar
antibodi
posit
sampl
without
fals
posit
result
use
enzym
immunoassay
eia
andor
immunoblot
overal
result
clearli
demonstr
serolog
diagnosi
sarscov
remain
earli
stage
develop
technic
improv
requir
particularli
respect
use
sar
specif
eia
diagnosi
sever
acut
respiratori
syndrom
sar
caus
new
coronaviru
sarscov
major
import
assist
control
futur
sar
epidem
drosten
et
al
ksiazek
et
al
peiri
et
al
b
kuiken
et
al
world
health
organ
help
laboratori
world
develop
laboratori
capabl
global
refer
network
initi
coordin
assist
provis
evalu
diagnost
tool
detect
sarscov
b
sinc
initi
epidem
start
novemb
southeast
china
spread
global
least
three
separ
laboratori
infect
incid
occur
secondari
case
demonstr
need
constant
vigil
reliabl
diagnost
tool
heymann
et
al
acut
phase
sar
rtpcr
method
pioneer
sever
laboratori
fastest
sensit
method
detect
viral
genom
appropri
use
diagnosi
first
day
ill
onset
signific
variat
found
viru
load
differ
patient
clinic
sampl
may
relat
sever
diseas
time
qualiti
sampl
peiri
et
al
b
consequ
current
knowledg
neg
rtpcr
result
interpret
exclud
sarscov
infect
detect
antibodi
sarscov
therefor
current
gold
standard
confirm
sar
infect
wu
et
al
serolog
assay
base
fix
infect
cell
use
immunofluoresc
assay
ifa
sarscov
viru
specif
enzym
immunoassay
eia
develop
mani
differ
laboratori
worldwid
one
way
assess
prepared
diagnost
laboratori
global
conduct
extern
qualiti
assur
eqa
program
provid
character
serum
specimen
contain
sarscov
specif
antibodi
collabor
distribut
panel
sampl
consist
antisarscov
posit
neg
human
sera
serum
materi
obtain
sar
infect
patient
provid
variou
countri
sarscov
case
occur
sera
check
sarscov
infect
inocul
vero
cell
cultur
three
passag
rtpcr
sera
dilut
human
freshli
frozen
plasma
neg
hbv
hcv
heat
c
h
lyophil
easi
distribut
test
two
refer
laboratori
specif
activ
unspecif
bind
analyz
sensit
differ
assay
eqa
panel
consist
sequenti
serum
dilut
result
sampl
low
high
antibodi
titer
sarscov
well
definit
sarscov
neg
sampl
posit
sera
patient
china
uk
germani
clear
clinic
diagnosi
sar
posit
sera
conscienti
analyz
expert
laboratori
china
germani
antisar
reactiv
ifa
eia
neutral
test
neg
sampl
consist
human
plasma
collect
sar
outbreak
germani
found
reactiv
sar
specif
diagnost
assay
analysi
specif
two
sera
known
nonspecif
reactiv
cell
mitochondri
structur
includ
present
result
first
eqa
studi
sarscov
serolog
diagnosi
studi
intend
diagnost
profici
test
includ
certif
public
anonym
result
thirti
laboratori
countri
europeanmiddl
eastern
australianasianoceanian
american
african
particip
see
later
particip
institut
includ
member
intern
sar
refer
verif
laboratori
network
well
nation
region
sar
refer
laboratori
three
commerci
laboratori
particip
receiv
code
panel
sampl
distribut
normal
mail
sampl
resuspend
l
distil
water
use
particip
ask
analyz
materi
diagnost
assay
use
sarscov
diagnosi
inform
typeformat
test
method
use
ifa
eia
immunoblot
neutral
assay
whether
inhous
assay
commerci
kit
also
collect
follow
two
criteria
chosen
minimum
requir
overal
profici
laboratori
detect
four
five
posit
sampl
correctli
ii
fals
posit
result
allow
indetermin
result
posit
neg
sampl
consid
evalu
laboratori
pass
minimum
requir
success
perform
tabl
three
laboratori
consid
evalu
failur
process
eqa
sampl
failur
laboratori
achiev
minimum
profici
standard
due
lack
sensit
andor
fals
posit
result
laboratori
use
ifa
detect
high
posit
sera
satisfactorili
perform
wors
low
titer
sera
detect
sar
antibodi
eight
laboratori
gener
problem
regard
specif
detect
neg
sampl
posit
assay
possibl
due
inadequ
intern
posit
neg
control
notabl
laboratori
good
perform
use
commerci
assay
compar
poor
perform
six
laboratori
perform
eia
detect
high
posit
sera
satisfactorili
wherea
one
laboratori
detect
low
posit
serum
comparison
ifa
laboratori
detect
sampl
one
laboratori
use
eia
base
sar
specif
peptid
show
high
reactiv
sampl
tabl
similar
result
obtain
peptid
base
eia
sar
evalu
sampl
could
avoid
real
serum
specimen
data
shown
gener
result
laboratori
use
one
diagnost
assay
better
laboratori
five
laboratori
use
ifa
assay
sar
diagnost
also
perform
eia
confirm
result
four
five
laboratori
best
perform
use
commerci
assay
one
inhous
assay
conclus
result
first
eqa
studi
sarscov
antibodi
diagnosi
indic
need
perform
improv
signific
number
laboratori
undertak
serolog
diagnosi
sarscov
sinc
laboratori
class
safeti
laboratori
facil
experi
develop
evalu
inhous
assay
commerci
assay
may
suitabl
sar
serolog
laboratori
low
volum
test
result
also
like
result
fact
limit
intern
work
perform
publish
technic
develop
assay
use
time
eqa
perform
follow
eqa
month
time
would
expect
show
substanti
improv
laboratori
chanc
develop
perform
inhous
assay
refin
test
strategi
laboratori
abl
develop
serolog
assay
partli
constraint
impos
laboratori
handl
sarscov
viru
contrast
eas
rtpcr
protocol
dissemin
implement
also
varieti
differ
assay
format
eg
ifa
eia
ib
antigen
sourc
eg
purifi
viru
recombin
sar
protein
sar
specif
peptid
contribut
variabl
perform
regard
strategi
test
peptid
base
assay
singl
test
avoid
sinc
appear
laboratori
use
approach
lack
specif
diagnost
algorithm
serolog
diagnosi
sar
requir
refin
approach
share
protocol
resourc
serolog
test
promot
guarante
dissemin
high
qualiti
assay
ensur
time
serolog
confirm
suspect
sar
case
meantim
commerci
assay
eia
chang
et
al
guo
et
al
et
al
evalu
assay
base
access
wellcharacter
sarscov
posit
sera
still
major
problem
laboratori
compani
work
task
recommend
diagnost
strategi
seroconvers
requir
diagnos
acut
infect
establish
serostatu
sensit
import
screen
due
low
seropreval
worldwid
sequenti
test
use
variou
differ
antigensmethodolog
requir
get
accept
posit
predict
valu
present
eqa
could
take
account
object
test
differ
test
strategi
therefor
difficult
assess
profici
particip
acut
diagnosi
serostatu
determin
test
seroconvers
use
pair
sera
sensit
assay
might
less
import
high
specif
avoid
fals
posit
result
nevertheless
highli
sensit
good
specif
serolog
assay
help
improv
diagnost
perform
laboratori
clear
benefit
patient
eqa
perform
sar
antibodi
diagnost
prove
clear
advantag
particip
either
demonstr
adequ
perform
qualiti
demonstr
need
necessari
technic
improv
train
laboratori
person
